Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exparel vs Bupivacaine for Post-Operative Pain in Lumbar Fusion
NCT06350981Phase 3Enrolling by invitation
- Sponsor
- Foundation for Orthopaedic Research and Education
- Start
- Apr 2024
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bupivacaine in postoperative pain, sponsored by Foundation for Orthopaedic Research and Education. Started Apr 2024; status: enrolling by invitation.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06350981.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06350981.